Organon & Co.: Osteoarthritis trials

The registry lists 15 Osteoarthritis studies with Organon & Co. as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 1 1Phase 2 2Phase 3 8Phase 4 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)CompletedNCT01980940Phase 1/2Results posted
• A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148)CompletedNCT01572675Results posted
• Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With OsteoarthritisCompletedNCT01554163Phase 3Results posted
• Survey of Osteoarthritis Real World Therapies (MK-0663-140)CompletedNCT01294696Results posted
• Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)CompletedNCT01685424
• A Study of Etoricoxib in Participants With Osteoarthritis Not Responding to Analgesic Drugs (MK-0663-142)WithdrawnNCT01429168Phase 4
• Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)CompletedNCT00542087Phase 3
• A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED)CompletedNCT00269191Phase 3
• A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)CompletedNCT00250445Phase 3
• Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)CompletedNCT00242489Phase 2
• A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)CompletedNCT00140972Phase 4
• A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)CompletedNCT00092781Phase 3
• A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)CompletedNCT00092768Phase 3
• An Investigational Drug in Patients With Osteoarthritis (0663-073)CompletedNCT00092755Phase 3
• Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)CompletedNCT00092703Phase 3